Brisbane-based Anteo (ASX:ADO) has announced the launch of a research partnership with the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland.
The partnership will be funded by the University’s Collaboration and Industry Engagement Fund (CIEF) grants program.
The CIEF program encourages industry-linked research and provides seed-funding as a means of generating high quality ARC/NHMRC applications.
The research partnership provides Anteo with a stronger basis for commitment to an ARC or NHMRC-funded project in the future.
Anteo uses its patented technology to develop, manufacture and commercialise proprietary surface coatings for use in healthcare, life sciences and other applications.
The technology is applied in the Mix&Go product range that is designed to provide solutions to the challenge of establishing highly functional interfaces between fragile biomolecules and synthetic, and often incompatible, materials.
The technology to be developed in this new project aims to improve patient clinical practice by combining several advanced imaging technologies onto a single particle using a simple approach.
According to Dr Geoff Cumming, CEO Anteo Technologies, “This research partnership is a strong endorsement of the potential for Mix&Go in the in vivo area and is the second announcement we have made relating to in vivo applications for Mix&Go in recent weeks.
"This project should also deliver additional data that confirms the broad applicability of our platform technology in the in vivo space,” he said. “This project will see Anteo’s leading scientists prepare the necessary 'nanoparticles' activated by Mix&Go for the project. This research will be undertaken at the University over a one year period and UQ will engage a research fellow to carry out the work.”
Dr Charlie Huang, Anteo's Head of New Technologies said: “There is a growing need for flexible approaches to attaching multiple imaging and targeting moieties to sub-micron particles, including nanoparticles.
“These particles have broad application in the fields of medical and diagnostic imaging and Anteo's Mix&Go metal-complex technology can provide a flexible and simple method to enable such attachments.”
Professor Andrew Whittaker, of the AIBN, said: “Anteo Technologies is an important partner of the AIBN and is an active participant in the institute’s Industrial Affiliate Program. We are confident that this research partnership will enhance the likelihood of success for future funding applications to ARC Linkage or NHMRC Development schemes.